Publication | Open Access

The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5)

CardiomyopathyHeart FailureDevice TherapyCardiovascular DiseaseImplantable Cardioverter-defibrillator TherapyMyocardial InfarctionMedicineCardiologyEmergency MedicineAnesthesiologyCardiac Arrest